Buscar
Mostrando ítems 21-30 de 1360
Plasmodium vivax vaccine: What is the best way to go?
(Frontiers Media, 2023)
Long lasting BCG protection against leprosy
(2007)
Background: BCG vaccine protects against leprosy.
Objectives: Estimate BCG protection against leprosy by age by age.
Methods: A case control study with 226 cases of leprosy and 857 controls. BCG vaccination was ascertained ...
Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine up to 8.4 years of follow-up
(Landes BioscienceAustinEUA, 2012)
Rotavirus genotypes in children with gastroenteritis assisted in two public hospitals from Chile: viral strains circulating in a country without a universal vaccination against rotavirus
(SOC CHILENA INFECTOLOGIA, 2012)
Background: Rotavirus is the main cause of severe gastroenteritis (GE) in children. Two vaccines currently available have proven efficacy against the predominant genotypes. Rotavirus genotypes vary both geographically ...
Long-term stability studies on protection against Newcastle disease by commercial live vaccine used in Brazil
(Academic Press Ltd Elsevier B.V. Ltd, 2009-08-01)
The thermostability (TS) and efficacy offered by live vaccines against Newcastle disease strains B 1, La Sota, VG-GA and Ulster, produced or imported by four Brazilian laboratories, were evaluated during their validity ...
Protein Antigens Increase the Protective Efficacy of a Capsule-Based Vaccine against Staphylococcus aureus in a Rat Model of Osteomyelitis
(American Society for Microbiology, 2014-01)
Staphylococcus aureus is an invasive bacterial pathogen, and antibiotic resistance has impeded adequate control of infections caused by this microbe. Moreover, efforts to prevent human infections with single-component S. ...
Adjuvants and delivery systems for antifungal vaccines: Current state and future developments
(Oxford Univ Press, 2015)
Rotavirus vaccines for the developing world
(Lippincott Williams, 2009)
The authors discuss the most relevant information in the field of rotavirus vaccines
published from October 2007 to June 2009; new information on the virus, host
response and disease burden that relate to our understanding ...
Heterogeneities in dengue spatial-temporal transmission in Brazilian cities and its influence on the optimal age of vaccination
(2019-02-06)
Background: The development of a safe and effective vaccine is considered crucial for dengue transmission control since vetor control has been failed; some potential candidates are currently in test, and in this context ...
Dendritic cell-based vaccine efficacy: Aiming for hot spots
(Frontiers Research Foundation, 2015-03)
Many approaches for cancer immunotherapy have targeted dendritic cells (DCs), directly or indirectly, for the induction of antitumor immune responses. DC-based vaccines have been developed using a wide variety of ex vivo ...